FDA To Host Webinar on Electromagnetic Compatibility of In Vitro Diagnostic Devices
The FDA is hosting a webinar on February 2 from 1:00-2:00pm ET for interested stakeholders to discuss the final guidance Electromagnetic Compatibility (EMC) of Medical Devices and its applicability to in vitro diagnostic (IVD) devices.
The FDA announced that during this webinar it will:
- Clarify recommendations for electromagnetic compatibility information to include in an IVD premarket submission.
- Help manufacturers and FDA staff use the FDA-recognized standards and partially recognized standards for the evaluation of electromagnetic compatibility of IVDs.
The final guidance was issued on June 6, 2022. It provides the FDA’s recommendations on testing to assess the EMC of medical devices as well as information to include in the labeling. This guidance applies to medical devices, including IVDs and accessories that are electrically powered or have functions or sensors that are implemented using electrical or electronic circuitry.
Attendees do not need to pre-registration for the webinar. The link to attend is available here.
Related Articles
-
Effective February 7, the agency will conduct inspections across all commodities, as well as mission-critical foreign and domestic inspections.
-
The CERSI program was established to foster robust and innovative approaches to advance regulatory science through collaborative interactions with FDA scientific experts.
-
The draft guidance proposes updates to clarify how the Breakthrough Devices Program may be applicable to certain medical devices that promote health equity, as well as considerations in designating eligible devices that may benefit populations impacted by disparities in health…
-
As of June 1, 2022, the Center for Devices and Radiological Health plans to accept all non-COVID in vitro diagnostic (IVD) pre-submissions.
